Sign inJoin waitlistJoin the waitlist

Shelly Lo

Medical Director at Rush Lisle · Rush University Medical Center

Credentials: · · · ·

History

Rush University Medical Center
Present
Rush University Medical Center
Present

Hospice and Palliative Medicine
2007–2008
University of Pittsburgh
2004–2007
Hematology and Medical Oncology
Mount Sinai Hospital
2001–2004
Internal Medicine-Pediatrics
Albany Med Health System
1997–2001
State University of New York Upstate Medical University
1993–1997

Research

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
Journal of Clinical Oncology · 2010 · First of 11 authors · Corresponding · 252 citations
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer:…
JAMA Oncology · 2020 · 187 citations
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation
Anticancer Research · 2010 · 120 citations

Kathy Albain
8 papers
Dawn Hershman
5 papers
Patricia Robinson
5 papers
Katherine Crew
4 papers
Alison Conlin
3 papers
Ana Leon
3 papers
Andrea Kaster
3 papers
Banu Arun
3 papers
Cathy Graham
3 papers
CD
Claudia Deyoung
3 papers
Corrine Zarwan
3 papers
DM
Debra Mangino
3 papers

Clinical trials

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Loyola University
2007–2015
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Site PI · Recruiting
SWOG Cancer Research Network
2018–2036
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2017–2027